Skip to main content
. 2022 May 11;17(1):31. doi: 10.5334/gh.1120

Table 2.

Prevalence of awareness, treatment, and control of hypertension in the hypertensive population of the Tehran Cohort Study (n = 3288).


AWARENESS TREATMENT CONTROL CONTROL AMONG TREATED

Overall, n (%) 2242 (68.2) 1752 (53.3) 1328 (40.4) 1023 (58.4)

Age, year, n (%)

    35–44 143 (39.7) 76 (21.1) 76 (21.1) 47 (61.8)

    45–54 403 (57.9) 281 (40.4) 238 (34.2) 171 (60.9)

    55–64 727 (72.1) 569 (56.4) 429 (42.6) 328 (57.6)

    65–74 624 (78.0) 529 (66.1) 391 (48.9) 317 (59.9)

    ≥75 345 (81.6) 297 (70.0) 194 (45.8) 160 (53.9)

p-value <0.001 <0.001 <0.001 0.378

Sex, n (%)

    Men 951 (63.4) 766 (51.1) 565 (37.7) 451 (58.9)

    Women 1291 (72.2) 986 (55.1) 763 (42.7) 572 (58.0)

p-value <0.001 0.020 0.004 0.716

Marital status, n (%)

    Married 2224 (68.3) 1737 (53.3) 1316 (40.4) 1013 (58.3)

    Non-married 17 (58.6) 15 (51.7) 11 (37.9) 10 (66.7)

p-value 0.266 0.864 0.788 0.514

Ethnicity, n (%)

    Fars 1135 (69.3) 906 (55.3) 687 (41.9) 547 (60.4)

    Azari 674 (69.5) 522 (53.8) 385 (39.7) 288 (55.2)

    Gilak 80 (61.5) 64 (49.2) 52 (40.0) 39 (60.9)

    Lor 71 (61.7) 43 (37.4) 40 (34.8) 24 (55.8)

    Kurd 49 (71.0) 40 (58.0) 30 (43.5) 26 (65.0)

    Mixed 171 (63.3) 125 (46.3) 96 (35.6) 68 (54.4)

    Other 48 (66.7) 41 (56.9) 31 (43.1) 25 (61.0)

    Immigrants/Refugees 12 (60.0) 9 (45.0) 5 (25.0) 5 (55.6)

    P-value 0.166 0.002 0.301 0.580

Education, year, n (%)

    Illiterate 315 (80.2) 261 (66.4) 160 (40.7) 129 (49.4)

    (1–5) 333 (73.2) 257 (56.5) 163 (35.8) 117 (45.5)

    (6–12) 1099 (66.2) 854 (51.4) 678 (40.8) 530 (62.1)

    >12 493 (63.5) 379 (48.8) 325 (41.9) 246 (64.9)

P-value <0.001 <0.001 0.188 <0.001

Body mass index, kg/m2, n (%)

    <20 27 (61.4) 19 (43.2) 17 (38.6) 10 (52.6)

    20–24.9 345 (60.1) 277 (48.2) 230 (40.0) 172 (62.1)

    25–29.9 874 (66.2) 692 (52.4) 538 (40.8) 420 (60.7)

    30–34.9 656 (73.5) 514 (57.6) 359 (40.2) 282 (54.9)

    ≥35 304 (73.6) 220 (53.3) 167 (40.4) 122 (55.5)

P-value <0.001 0.005 0.996 0.150

Diabetes, n (%)

    No 1522 (62.6) 1130 (46.5) 880 (36.2) 653 (57.8)

    Yes 720 (83.9) 621 (72.4) 447 (52.1) 369 (59.4)

p-value <0.001 <0.001 <0.001 0.507

Hyperlipidemia, n (%)

    No 919 (54.7) 702 (41.8) 473 (28.1) 357 (50.9)

    Yes 1323 (82.3) 1049 (65.3) 854 (53.1) 665 (63.4)

P-value <0.001 <0.001 <0.001 <0.001

Chronic kidney disease, n (%)

    No 2193 (67.8) 1710 (52.9) 1296 (40.1) 996 (58.2)

    Yes 49 (89.1) 42 (76.4) 32 (58.2) 27 (64.3)

P-value 0.001 0.001 0.007 0.433

Tobacco user, n (%)

    Current 300 (60.2) 232 (46.6) 185 (37.1) 146 (62.9)

    Former 133 (72.7) 119 (65.0) 85 (46.4) 72 (60.5)

    Never 1808 (69.4) 1399 (53.7) 1057 (40.6) 804 (57.5)

P-value <0.001 <0.001 0.082 0.262

Opium consumption, n (%)

    No 2113 (68.4) 1640 (53.1) 1253 (40.5) 958 (58.4)

    Yes 121 (65.4) 106 (57.3) 72 (38.9) 63 (59.4)

P-value 0.402 0.262 0.663 0.836

Alcohol consumption, n (%)

    No 2085 (68.9) 1626 (53.8) 1230 (40.7) 941 (57.9)

    Yes 146 (58.4) 115 (46.0) 87 (34.8) 72 (62.6)

P-value 0.001 0.018 0.069 0.320

Physical activity, n (%)

    Low 606 (77.8) 493 (63.3) 342 (43.9) 268 (54.4)

    Intermediate 1262 (68.3) 967 (52.3) 737 (39.9) 563 (58.2)

    High 357 (56.5) 277 (43.8) 234 (37.0) 179 (64.6)

P-value <0.001 <0.001 0.028 0.022

Categorical data are reported as numbers (percentage in the row) among individuals with hypertension.

P-values are calculated for subgroups in each column independently.